Gast ::
| Hauptseite > Publikationsdatenbank > mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia > print |
| Hauptseite > Publikationsdatenbank > mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia > print |
| 001 | 874445 | ||
| 005 | 20230117110852.0 | ||
| 024 | 7 | _ | |a 10.1002/hbm.24976 |2 doi |
| 024 | 7 | _ | |a 1065-9471 |2 ISSN |
| 024 | 7 | _ | |a 1097-0193 |2 ISSN |
| 024 | 7 | _ | |a 2128/25107 |2 Handle |
| 024 | 7 | _ | |a pmid:32150317 |2 pmid |
| 024 | 7 | _ | |a WOS:000540009000014 |2 WOS |
| 024 | 7 | _ | |a altmetric:86590096 |2 altmetric |
| 037 | _ | _ | |a FZJ-2020-01446 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Régio Brambilla, Cláudia |0 P:(DE-Juel1)171754 |b 0 |e Corresponding author |
| 245 | _ | _ | |a mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia |
| 260 | _ | _ | |a New York, NY |c 2020 |b Wiley-Liss |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1592912670_7373 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Consistent findings postulate disturbed glutamatergic function (more specifically a hypofunction of the ionotropic NMDA receptors) as an important pathophysiologic mechanism in schizophrenia. However, the role of the metabotropic glutamatergic receptors type 5 (mGluR5) in this disease remains unclear. In this study, we investigated their significance (using [11C]ABP688) for psychopathology and cognition in male patients with chronic schizophrenia and healthy controls. In the patient group, lower mGluR5 binding potential (BPND) values in the left temporal cortex and caudate were associated with higher general symptom levels (negative and depressive symptoms), lower levels of global functioning and worse cognitive performance. At the same time, in both groups, mGluR5 BPND were significantly lower in smokers (F [27,1] = 15.500; p = .001), but without significant differences between the groups. Our findings provide support for the concept that the impaired function of mGluR5 underlies the symptoms of schizophrenia. They further supply a new perspective on the complex relationship between tobacco addiction and schizophrenia by identifying glutamatergic neurotransmission—in particularly mGluR5—as a possible connection to a shared vulnerability. |
| 536 | _ | _ | |a 573 - Neuroimaging (POF3-573) |0 G:(DE-HGF)POF3-573 |c POF3-573 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Veselinović, Tanja |0 0000-0001-7906-6966 |b 1 |
| 700 | 1 | _ | |a Rajkumar, Ravichandran |0 P:(DE-Juel1)164396 |b 2 |
| 700 | 1 | _ | |a Mauler, Jörg |0 P:(DE-Juel1)144215 |b 3 |
| 700 | 1 | _ | |a Orth, Linda |0 P:(DE-Juel1)172782 |b 4 |
| 700 | 1 | _ | |a Ruch, Andrej |0 0000-0002-0524-347X |b 5 |
| 700 | 1 | _ | |a Ramkiran, Shukti |0 P:(DE-Juel1)169201 |b 6 |
| 700 | 1 | _ | |a Heekeren, Karsten |0 0000-0001-5105-1922 |b 7 |
| 700 | 1 | _ | |a Kawohl, Wolfram |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Wyss, Christine |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Kops, Elena Rota |0 P:(DE-Juel1)131788 |b 10 |
| 700 | 1 | _ | |a Scheins, Jürgen |0 P:(DE-Juel1)131791 |b 11 |u fzj |
| 700 | 1 | _ | |a Tellmann, Lutz |0 P:(DE-Juel1)131797 |b 12 |u fzj |
| 700 | 1 | _ | |a Boers, Frank |0 P:(DE-Juel1)131752 |b 13 |u fzj |
| 700 | 1 | _ | |a Neumaier, Bernd |0 P:(DE-Juel1)166419 |b 14 |
| 700 | 1 | _ | |a Ermert, Johannes |0 P:(DE-Juel1)131818 |b 15 |u fzj |
| 700 | 1 | _ | |a Herzog, Hans |0 P:(DE-Juel1)131768 |b 16 |u fzj |
| 700 | 1 | _ | |a Langen, Karl‐Josef |0 P:(DE-Juel1)131777 |b 17 |
| 700 | 1 | _ | |a Jon Shah, N. |0 0000-0002-8151-6169 |b 18 |
| 700 | 1 | _ | |a Lerche, Christoph |0 P:(DE-Juel1)164254 |b 19 |
| 700 | 1 | _ | |a Neuner, Irene |0 P:(DE-Juel1)131781 |b 20 |u fzj |
| 773 | _ | _ | |a 10.1002/hbm.24976 |g p. hbm.24976 |0 PERI:(DE-600)1492703-2 |n 10 |p 2762-2781 |t Human brain mapping |v 41 |y 2020 |x 1097-0193 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/874445/files/Invoice_R-2020-00374.pdf |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/874445/files/Invoice_R-2020-00374.pdf?subformat=pdfa |x pdfa |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/874445/files/hbm.24976%281%29.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/874445/files/hbm.24976%281%29.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:874445 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 0 |6 P:(DE-Juel1)171754 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)164396 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)144215 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 6 |6 P:(DE-Juel1)169201 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 10 |6 P:(DE-Juel1)131788 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 11 |6 P:(DE-Juel1)131791 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 12 |6 P:(DE-Juel1)131797 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 13 |6 P:(DE-Juel1)131752 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 14 |6 P:(DE-Juel1)166419 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 15 |6 P:(DE-Juel1)131818 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 16 |6 P:(DE-Juel1)131768 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 17 |6 P:(DE-Juel1)131777 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 19 |6 P:(DE-Juel1)164254 |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 20 |6 P:(DE-Juel1)131781 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-573 |2 G:(DE-HGF)POF3-500 |v Neuroimaging |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b HUM BRAIN MAPP : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | p | c | |a APC keys set |2 APC |0 PC:(DE-HGF)0000 |
| 915 | p | c | |a Local Funding |2 APC |0 PC:(DE-HGF)0001 |
| 915 | p | c | |a DFG OA Publikationskosten |2 APC |0 PC:(DE-HGF)0002 |
| 915 | p | c | |a DOAJ Journal |2 APC |0 PC:(DE-HGF)0003 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-11-20170113 |k INM-11 |l Jara-Institut Quantum Information |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-4-20090406 |k INM-4 |l Physik der Medizinischen Bildgebung |x 1 |
| 920 | 1 | _ | |0 I:(DE-82)080010_20140620 |k JARA-BRAIN |l JARA-BRAIN |x 2 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-5-20090406 |k INM-5 |l Nuklearchemie |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-11-20170113 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-4-20090406 |
| 980 | _ | _ | |a I:(DE-82)080010_20140620 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | _ | _ | |a APC |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a APC |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|